Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity

FGFRs are considered essential targets for cancer therapy. We previously reported that msFGFR2c, a Ser252Trp mutant soluble ectodomain of FGFR2IIIc, inhibited tumor growth by blocking FGF signaling pathway. However, the underlying molecular mechanism is still obscure. In this study, we reported that...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhong, Liu, Ge, Zhang, Guang-Lin, Li, Jun, He, Yan-Qing, Zhang, Shu-Shu, Wang, Yi, He, Wei-Yi, Cheng, Guo-Hua, Yang, Xuesong, Xu, Jun, Wang, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356568/
https://www.ncbi.nlm.nih.gov/pubmed/28049184
http://dx.doi.org/10.18632/oncotarget.12067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356568/
https://www.ncbi.nlm.nih.gov/pubmed/28049184
http://dx.doi.org/10.18632/oncotarget.12067

Ejemplares similares